GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharmadrug PHRX.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.01

0.00%

Close of 5 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Pharmadrug — daily PHRX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Pharmadrug on TradingView ↗
Market value
C$522,800
Last close × shares
Volume
1k
Shares, 5 Nov 2026

About Pharmadrug

Its shares trade on Canadian Securities Exchange under the ticker PHRX.CN. It has been listed since 16 August 2018. In the fiscal year to 31 December 2021, it reported revenue of C$7,009 and a net loss of C$5.9m. At that date it held total assets of C$19.5m and shareholders' equity of C$16.9m.

Pharmadrug Inc is a CA-based company operating in industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-08-16. PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The firm is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.

Figures and description from our data supplier, not checked against the company's own report.

More about Pharmadrug →

Latest on Pharmadrug

Our reporting

We have not reported on Pharmadrug yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Pharmadrug's ticker?

Pharmadrug trades as PHRX.CN on Canadian Securities Exchange, under ISIN CA71716W2040.

What was Pharmadrug's last closing price?

0.01 on 5 Nov 2026. The figure is in CAD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.